NCT00541970 2018-08-17
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
GlaxoSmithKline
Phase 1 Completed
Clinical Trials
7 trialsNCT00426361 2018-07-20
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT02015169 2018-01-17
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Samsung Medical Center
Phase 2 Completed
NCT00490061 2017-03-06
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
Stanford University
Phase 2 Terminated
NCT00827554 2016-04-01
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT01394497 2013-02-18
Use of N-Acetylcysteine During Liver Procurement
Azienda Ospedaliera di Padova
Phase 2 Completed
NCT01022905 2010-03-01
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
University Hospital, Geneva
Phase 4 Completed